DK2957280T3 - Farmaceutisk faststofsammensætning af cytisin og fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutisk faststofsammensætning af cytisin og fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK2957280T3
DK2957280T3 DK15001790.3T DK15001790T DK2957280T3 DK 2957280 T3 DK2957280 T3 DK 2957280T3 DK 15001790 T DK15001790 T DK 15001790T DK 2957280 T3 DK2957280 T3 DK 2957280T3
Authority
DK
Denmark
Prior art keywords
cytisin
procedures
preparing
solid composition
pharmaceutical solid
Prior art date
Application number
DK15001790.3T
Other languages
English (en)
Inventor
Katarzyna Berdzinska
Hanna Kieronska
Marek Milewski
Malgorzata Nawrocka
Marta Klepczynska
Original Assignee
Bonteque Consulting Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54011933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2957280(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bonteque Consulting Ltd filed Critical Bonteque Consulting Ltd
Application granted granted Critical
Publication of DK2957280T3 publication Critical patent/DK2957280T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK15001790.3T 2014-06-18 2015-06-17 Farmaceutisk faststofsammensætning af cytisin og fremgangsmåde til fremstilling deraf DK2957280T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL408608A PL408608A1 (pl) 2014-06-18 2014-06-18 Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania

Publications (1)

Publication Number Publication Date
DK2957280T3 true DK2957280T3 (da) 2019-07-22

Family

ID=54011933

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15001790.3T DK2957280T3 (da) 2014-06-18 2015-06-17 Farmaceutisk faststofsammensætning af cytisin og fremgangsmåde til fremstilling deraf

Country Status (12)

Country Link
EP (1) EP2957280B1 (da)
CY (1) CY1121986T1 (da)
DK (1) DK2957280T3 (da)
ES (1) ES2732711T3 (da)
HR (1) HRP20191217T1 (da)
HU (1) HUE044804T2 (da)
LT (1) LT2957280T (da)
PL (2) PL408608A1 (da)
PT (1) PT2957280T (da)
RS (1) RS58983B1 (da)
SI (1) SI2957280T1 (da)
TR (1) TR201909836T4 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201602145D0 (en) * 2016-02-05 2016-03-23 Achieve Pharma Uk Ltd Salt
EP3598968A1 (en) 2018-07-23 2020-01-29 Adamed Pharma S.A. Solid pharmaceutical cytisine composition
BG67408B1 (bg) * 2019-04-12 2022-01-17 Софарма Ад Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости
CN115487158A (zh) * 2021-06-18 2022-12-20 北京万全德众医药生物技术有限公司 一种金雀花碱片剂及其制备方法
AU2024400864A1 (en) * 2023-12-12 2026-06-25 Achieve Life Sciences, Inc. Cytisine formulations
US20250186416A1 (en) * 2023-12-12 2025-06-12 Achieve Life Sciences, Inc. Smoking cessation compounds having reduced nitrosamines and associated methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59500217A (ja) 1982-02-22 1984-02-16 ベロルススキ−　ナウチノ−　イスレドワ−チエルスキ−　サニタルノ−　ギギエニチエスキ−　インスチツ−ト 抗ニコチン効果を有する製剤およびその製造法
ATE182894T1 (de) 1996-05-20 1999-08-15 Andrej Zinovyevich Vitik Phosphorhaltige cytisin-derivate
BG65536B1 (bg) 2004-04-16 2008-11-28 "Софарма" Ад Лекарствена форма, съдържаща цитизин
EP2233134A1 (en) * 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
PL220354B1 (pl) * 2012-11-19 2015-10-30 Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania

Also Published As

Publication number Publication date
HRP20191217T1 (hr) 2019-10-18
PL408608A1 (pl) 2015-12-21
HUE044804T2 (hu) 2019-11-28
ES2732711T3 (es) 2019-11-25
PT2957280T (pt) 2019-07-23
PL2957280T3 (pl) 2019-09-30
LT2957280T (lt) 2019-07-25
RS58983B1 (sr) 2019-08-30
EP2957280B1 (en) 2019-04-17
EP2957280A1 (en) 2015-12-23
TR201909836T4 (tr) 2019-07-22
SI2957280T1 (sl) 2019-08-30
CY1121986T1 (el) 2020-10-14

Similar Documents

Publication Publication Date Title
DK3204413T3 (da) Bærerantistofsammensætninger og fremgangsmåder til fremstilling og anvendelse heraf
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
IL258931A (en) Therapeutic compounds and methods
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3092256T3 (da) Forbindelser og sammensætninger til immunterapi
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3277270T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3212778T3 (da) Fremgangsmåder og sammensætninger til stabilisering af trans-splejsning af intein-modificerede proteaser
DK3200615T3 (da) Kaloriefrie sødestoffer og fremgangsmåder til syntetisering
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK2924093T3 (da) Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3102184T3 (da) Stabile formuleringer af peptider og fremgangsmåder til fremstilling
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3204398T3 (da) Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer
DK3129779T3 (da) Fremgangsmåder og sammensætninger til påvisning af fejlfoldede proteiner
DK3495482T3 (da) Fremgangsmåde til fremstilling af dna-enhedssammensætning og fremgangsmåde til frembringelse af concatenat-dna
DK3237054T3 (da) Indretning til fremstilling og påføring af en medicinsk substans
DK3148517T3 (da) Sammensætninger og fremgangsmåder til fremme af knogledannelse
DK3380525T3 (da) Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf
DK3110446T3 (da) Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme
DK3319609T3 (da) Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin